VAERS Explorer
Back to explore

Report #2874688

Received Nov 24, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
—
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS2UNK—

Symptoms (2)

FatigueMyalgia

Symptom narrative

Muscle ache; Tiredness; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of muscle pain in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced muscle pain (Verbatim: Muscle ache) and tiredness (Verbatim: Tiredness). The outcome of the muscle pain and tiredness were not reported. It was unknown if the reporter considered the muscle pain and tiredness to be related to Shingrix. It was unknown if the company considered the muscle pain and tiredness to be related to Shingrix. Additional Information: GSK receipt date: 18-NOV-2025 The reporter asked how long muscle ache and tiredness last after the second dose. The batch number was not provided, and we were unable to contact the reporter.